BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• FDA

  Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia

  Tyra Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead precision medicine program, TYRA-300, for the treatment of achondroplasia.

  August 1, 2023

   · 

  7 min read
• InMode to Present at Upcoming Investor Conferences and Events - August 1, 2023

  InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following investor conferences and events in August.

  August 1, 2023

   · 

  1 min read
• Pharm Country

  Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic

  Coeptis Therapeutics Holdings, Inc. announced that it has submitted a 513(g) request to the U.S. Food and Drug Administration (FDA) for an in vitro companion diagnostic test designed to be used with anti-CD38 monoclonal antibody therapies.

  August 1, 2023

   · 

  5 min read
• Business

  ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

  ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three and six months ended June 30, 2023 on Monday, August 14, 2023 after the close of trading on the U.S. financial markets.

  August 1, 2023

   · 

  2 min read
• Drug Development

  ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071 for Hypoxic Ischemic Encephalopathy in Newborns

  ReAlta Life Sciences today announced dosing of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE) in newborns.

  August 1, 2023

   · 

  3 min read
• Business

  Biosero Appoints Rob Harkness as Chief Technology Officer

  Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Rob Harkness, PhD, to the position of Chief Technology Officer.

  August 1, 2023

   · 

  3 min read
• Business

  TheracosBio Appoints Brian Connelly as Chief Executive Officer

  TheracosBio today announced the appointment of Brian Connelly as President and Chief Executive Officer.

  August 1, 2023

   · 

  2 min read
• Business

  iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

  iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases.

  August 1, 2023

   · 

  7 min read
• Business

  Gamida Cell to Report Second Quarter 2023 Financial Results

  Gamida Cell Ltd. today announced that the company will release its financial results for the second quarter ended June 30, 2023 on Monday, August 14, 2023.

  August 1, 2023

   · 

  1 min read
• Biotech Beach

  Sonendo’s Enhanced CleanFlow™ Procedure Instrument Now Indicated for Use on Anterior Teeth

  Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced enhancements to its CleanFlow™ Procedure Instrument, which are designed to improve its applicability and effectiveness.

  August 1, 2023

   · 

  3 min read